ASO Author Reflections: Predicting High-Risk Oncotype DX Recurrence Scores as a Strategy for Assessing Neoadjuvant Chemotherapy Eligibility. Article uri icon

Overview

abstract

  • null

publication date

  • October 30, 2018

Research

keywords

  • Breast Neoplasms

Identity

Scopus Document Identifier

  • 85055995277

Digital Object Identifier (DOI)

  • 10.1245/s10434-018-6989-1

PubMed ID

  • 30377915

Additional Document Info

volume

  • 25

issue

  • Suppl 3